Agent for the prevention or treatment of cataracts
An agent for the prevention or treatment of cataracts comprising a proanthocyanidin oligomer is provided. The oral administration or application to the eyes of the agent of the invention produces a sufficient preventive or therapeutic effect against cataracts caused by oxidative disorders.
Latest Kikkoman Corporation Patents:
- SOY SAUCE AND SOY SAUCE-LIKE SEASONING WITH EXCELLENT AROMA, METHOD FOR SUPPRESSING HEAT-DETERIORATED SMELL, CONTAINER-PACKED COMPOSITION WITH SUPPRESSED HEAT-DETERIORATED SMELL AND COMPOSITION FOR SUPPRESSING HEAT-DETERIORATED SMELL
- Method for producing alkaline phosphatase, alkaline phosphatase obtained using said method, and vector and transformant for production thereof
- Enzyme and method for assaying pentosidine using same
- Quantification method of ethanolamine phosphate, oxidoreductase for quantification, composition for quantification, kit for quantification and sensor for quantification
- METHOD FOR IMPROVING THE STABILITY OF A COMPOSITION COMPRISING A FLAVIN-DEPENDENT LACTATE DEHYDROGENASE
Claims
1. A method for the treatment or prevention of cataracts in a mammal, which method comprises administering to the mammal a therapeutically effective amount of a composition comprising at least one proanthocyanidin oligomer or a salt thereof, wherein the proanthocyanidin oligomer is from a dimer to a 30-mer comprising monomers each of which has the formula ##STR2## wherein R.sub.1 is hydrogen or a hydroxyl group; R.sub.2, R.sub.3 and R.sub.4 are each independently hydrogen, a hydroxyl group or a methoxy group, provided that at least one of R.sub.2, R.sub.3 and R.sub.4 is a hydroxyl group; and R.sub.5 is hydrogen, a galloyl group or a glycopyranosyl group.
2. The method according to claim 1, wherein the mammal is a human.
3. The method according to claim 1, wherein the proanthocyanidin oligomer is from a dimer to a 10-mer.
4. The method according to claim 1, wherein the composition comprises a proanthocyanidin oligomer-containing extract obtained from a plant material.
5. The method according to claim 4, wherein the plant material is grape seeds, grape peel or pressed grape cake.
6. The method according to claim 1, wherein the composition is administered orally.
7. The method according to claim 1, wherein the composition is administered parenterally.
8. The method according to claim 1, wherein the composition is formulated as a tablet, a grain, a powder, a capsule, an eye drop or an injection solution.
9. The method according to claim 1, wherein the composition further comprises a binder, disintegrant, thickener, dispersant, reabsorption promoting agent, flavorant, buffer, surfactant, resolvent, preservative, emulsifier, isotonicity inducing agent, stabilier or pH modifier.
10. The method according to claim 8, wherein the composition is formulated as an injection solution, and the amount administered is a dosage of about 0.01 to 1000 mg, which dosage is administered once daily.
11. The method according to claim 8, wherein the composition is formulated as an eye drop with a concentration of the proanthocyanidin oligomer of 0.01 to 10% (w/w), and the amount administered is a dosage of one to two drops, which dosage is administered to the eye of the animal one to five times a day.
12. The method according to claim 6, wherein the composition is formulated as a food or an additive to a food or drink.
| 4698360 | October 6, 1987 | Masquelier |
| 4797421 | January 10, 1989 | Ariga et al. |
| 5196449 | March 23, 1993 | Magistretti et al. |
| 0 210 785 | April 1987 | EPX |
| 2 699 819 | July 1994 | FRX |
| 59-59638 | April 1984 | JPX |
| 61-16982 | January 1986 | JPX |
| 3-7232 | January 1991 | JPX |
| 3-200781 | September 1991 | JPX |
| 92 06695 | April 1992 | WOX |
| 93 24106 | December 1993 | WOX |
- Patent Abstracts of Japan, vol. 14, No. 470 (C-0769), 15 Oct. 1990 & JP 02 193930 A (Tsumura & Co), 31 Jul. 1990. Tissie et al., "Oxidative Stress and Lens Opacity: An Overall Approach to Screening Anticataractous Drugs," Ophthalmic Research, 20:27-30 (1980). Simonelli et al., "Oxidative Stress in Ocular Inflammation," Chibret International Journal of Opthalmology, 9:1-7 (1993). Spector et al., "Hydrogen Peroxide and Human Cataract," Experimental Eye Research, 33:673-681 (1981). Ariga & Asao, 1981, Agric. Biol. Chem. 45:2709-2712. Delle Monache et al., 1967, Ann. Chim. 57:1364-1371. R. Eastmond, 1973, J. Inst. Brew. 80:188-192. Fonknechten et al., 1983, J. Inst. Brew. 89:424-431. Hemingway et al., 1983, Phytochem. 22:275-281. Jacques et al., 1974, J.C.S. Perkin I pp. 2663-2671. S. Kumakura, 1993, Kagakukeizai (Chem. Econ.) 11;78-83. A.G.H. Lea, 1978, J. Sci. Fd Agric. 29:471-477. McMurrough et al., 1983, J. Sci. Food Agric. 34:62-72. Nonaka et al., 1982, Phytochem. 21:429-432. Nonaka et al., 1983 Phytochem. 22:237-241. Derwent WPI Acc. No. 84-123450/20. Derwent WPI Acc. No. 86-065473/10. Derwent WPI Acc. No. 91-300280/41. Derwent WPI Acc. No. 91-55559/08.
Type: Grant
Filed: Jan 6, 1997
Date of Patent: Sep 8, 1998
Assignee: Kikkoman Corporation (Noda)
Inventors: Jun Yamakoshi (Chiba), Toshiaki Ariga (Chiba), Hiroharu Ishikawa (Chiba), Yukihiko Iwai (Chiba), Tatuo Manaka (Chiba), Shigehiro Kataoka (Chiba), Katsumi Yuasa (Chiba), Mamoru Kikuchi (Chiba)
Primary Examiner: Zohreh Fay
Law Firm: Pennie & Edmonds LLP
Application Number: 8/779,097
International Classification: A61K 3135;
